Stay updated on Pembrolizumab for Lung Cancer Prevention Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab for Lung Cancer Prevention Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab for Lung Cancer Prevention Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    The page now displays the ClinicalTrials.gov record for the IMPRINT-Lung pembrolizumab study, including its study details, eligibility criteria, locations, outcomes, and documents.
    Difference
    57%
    Check dated 2026-11-08T11:40:09.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The footer revision changed from v3.7.2 to v3.8.0, while the study record remains inaccessible due to a 403 error.
    Difference
    0.2%
    Check dated 2026-11-01T12:24:39.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    A site-wide NIH announcement about the transition from “Artificial Intelligence” to “Super Intelligence” appears above the page content.
    Difference
    1%
    Check dated 2026-10-25T12:32:28.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The footer revision identifier changes from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-18T13:34:46.000Z thumbnail image
  6. Check
    36 days ago
    Change Detected
    Summary
    The site footer revision indicator changed from v3.7.0 to v3.7.1 while the study page remains unavailable with a 403 Forbidden message.
    Difference
    0.2%
    Check dated 2026-10-11T13:43:55.000Z thumbnail image
  7. Check
    58 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error, replacing the study record content with an access-denied screen. The additions include the 403 text and HTML header, while the detailed study content is not visible.
    Difference
    20%
    Check dated 2026-09-20T10:32:08.000Z thumbnail image

Stay in the know with updates to Pembrolizumab for Lung Cancer Prevention Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Lung Cancer Prevention Clinical Trial page.